Andrew F. Alexis, MD, MPH, FAAD

9 October 2026 New York, United States “Conference Welcome & Session Introduction; Recent Drug Approvals and Emerging Therapies for Patients With Skin of Color—2026 Update; GLP‑1 Agonists Therapy in Psoriasis and Hidradenitis Suppurativa: Clinical Utility and Aesthetic Considerations—Expert Panel; Ask Me Anything! Audience Q&A; Acne in Patients With Skin of Color: Disease State Update; Managing PIH After Acne: Evidence‑Based Approaches and Case Reviews; Acne, Rosacea, and HS Case-Based Approaches to Diagnosis & Treatment—Expert Panel; Ask Me Anything! Audience Q&A; Session Introduction; Psoriasis & Psoriatic Arthritis: Therapeutic Updates, Comorbidity Care, and Challenging Cases—Expert Panel; Atopic Dermatitis & Eczema Expert Panel: From Topicals to Systemics—Case‑Based Approaches; Ask Me Anything! Audience Q&A; Session Introduction; Navigating Complexity: Expert Approaches to Challenging Alopecia Cases in Skin of Color—Case-Based Panel Discussion; Ask Me Anything! Audience Q&A; Session Introduction; Ask Me Anything! Audience Q&A; Session Introduction; Ask Me Anything! Audience Q&A; Session Introduction; Ask Me Anything! Audience Q&A; Session Introduction; Ask Me Anything! Audience Q&A”